Specifically, the FDA indicated that a preclinical finding of pancreatic acinar cell tumors in rats was concerning enough to prevent approval at this time Xenoport said the FDA did acknowledge that it approved gabapentin for refractory epilepsy after similar findings, but said that was due to the severity of that condition The companies are assessing the next steps, according to the release "In our opinion, until there is new information, investors should assume Horizant's probability of approval in the foreseeable future is low," wrote Ladenburg Thalmann analyst Juan Sanchez, who downgraded the stock to a sell from a buy 
Share:  Specifically, the FDA indicated that a preclinical finding of pancreatic acinar cell tumors in rats was concerning enough to prevent approval at this time <span class="company">Xenoport</span> said the FDA did acknowledge that it approved gabapentin for refractory epilepsy after similar findings, but said that was due to the severity of that condition The companies are assessing the next steps, according to the release<span class="sent"> "In our opinion, until there is new information, investors should assume Horizant's probability of approval in the foreseeable future is low," wrote Ladenburg Thalmann analyst <span class="analyst">Juan Sanchez</span>, who downgraded the stock to a sell from a buy</span> Tweet this 

, Analysts at Ladenburg Thalmann initiate coverage of PGT Inc (PGTI) with a "buy" rating 
Share:  <span class="sent">, Analysts at <span class="analyst">Ladenburg Thalmann</span> initiate coverage of PGT Inc (<span class="company">PGTI</span>) with a "buy" rating</span> Tweet this 

, Analysts at Ladenburg Thalmann initiate coverage of Elizabeth Arden (RDEN) with a "buy" rating 
Share:  <span class="sent">, Analysts at <span class="analyst">Ladenburg Thalmann</span> initiate coverage of Elizabeth Arden (<span class="company">RDEN</span>) with a "buy" rating</span> Tweet this 

"HSN pulled it off without losing their core customers," said Nancy Hull, a securities analyst with Ladenburg Thalman, who has a buy recommendation on HSN's stock, which almost doubled since Labor Day 
Share:  <span class="sent">"<span class="company">HSN</span> pulled it off without losing their core customers," said <span class="analyst">Nancy Hull</span>, a securities analyst with Ladenburg Thalman, who has a buy recommendation on <span class="company">HSN</span>'s stock, which almost doubled since Labor Day</span> Tweet this 

, Analysts at Ladenburg Thalmann initiate coverage of Spherion (SFN) with a "buy" rating 
Share:  <span class="sent">, Analysts at <span class="analyst">Ladenburg Thalmann</span> initiate coverage of Spherion (<span class="company">SFN</span>) with a "buy" rating</span> Tweet this 

, Analysts at Ladenburg Thalmann upgrade AO Smith (AOS) from "neutral" to "buy" 
Share:  <span class="sent">, Analysts at <span class="analyst">Ladenburg Thalmann</span> upgrade AO Smith (<span class="company">AOS</span>) from "neutral" to "buy"</span> Tweet this 

Shares of Sallie Mae fell after Ladenburg Thalman analyst Brad Ball downgraded the student lender, citing its uncertain long term outlook for growth 
Share:  <span class="sent">Shares of <span class="company">Sallie Mae</span> fell after Ladenburg Thalman analyst <span class="analyst">Brad Ball</span> downgraded the student lender, citing its uncertain long term outlook for growth</span> Tweet this 

Ladenburg Thalman analyst Brad Ball ( BLL , news , people ) lowered his rating on the Reston, Va, company to "Neutral" from "Buy" and reduced his share price target to $1197, from $13 Shares of Sallie Mae ( SLM , news , people ), formally known as SLM Corp, fell 79 cents, or 67 percent, to $1102 in afternoon trading The stock has ranged from $311 to $1289 over the past year Earlier this week, the company posted a fourth quarter profit, compared a loss in the same quarter a year ago, partly as a result of higher revenue from fees and interest But results missed Wall Street expectations 
Share:  <span class="sent">Ladenburg Thalman analyst <span class="analyst">Brad Ball</span> ( BLL , news , people ) lowered his rating on the Reston, Va, company to "Neutral" from "Buy" and reduced his share price target to $1197, from $13</span> Shares of Sallie Mae ( <span class="company">SLM</span> , news , people ), formally known as <span class="company">SLM</span> Corp, fell 79 cents, or 67 percent, to $1102 in afternoon trading The stock has ranged from $311 to $1289 over the past year Earlier this week, the company posted a fourth quarter profit, compared a loss in the same quarter a year ago, partly as a result of higher revenue from fees and interest But results missed Wall Street expectations...<span class="sent">Ladenburg Thalman analyst <span class="analyst">Brad Ball</span> ( BLL , news , people ) lowered his rating on the Reston, Va, company to "Neutral" from "Buy" and reduced his share price target to $1197, from $13</span> Shares of Sallie Mae ( <span class="company">SLM</span> , news , people ), formally known as <span class="company">SLM</span> Corp, fell 79 cents, or 67 percent, to $1102 in afternoon trading The stock has ranged from $311 to $1289 over the past year Earlier this week, the company posted a fourth quarter profit, compared a loss in the same quarter a year ago, partly as a result of higher revenue from fees and interest But results missed Wall Street expectations Tweet this 

Ladenburg Thalman analyst Brad Ball ( BLL , news , people ) lowered his rating on the Reston, Va, company to "Neutral" from "Buy" and reduced his share price target to $1197, from $13 Shares of Sallie Mae ( SLM , news , people ), formally known as SLM Corp, fell 79 cents, or 67 percent, to $1102 in afternoon trading The stock has ranged from $311 to $1289 over the past year Earlier this week, the company posted a fourth quarter profit, compared a loss in the same quarter a year ago, partly as a result of higher revenue from fees and interest But results missed Wall Street expectations 
Share:  <span class="sent">Ladenburg Thalman analyst <span class="analyst">Brad Ball</span> ( BLL , news , people ) lowered his rating on the Reston, Va, company to "Neutral" from "Buy" and reduced his share price target to $1197, from $13</span> Shares of <span class="company">Sallie Mae</span> ( SLM , news , people ), formally known as SLM Corp, fell 79 cents, or 67 percent, to $1102 in afternoon trading The stock has ranged from $311 to $1289 over the past year Earlier this week, the company posted a fourth quarter profit, compared a loss in the same quarter a year ago, partly as a result of higher revenue from fees and interest But results missed Wall Street expectations...<span class="sent">Ladenburg Thalman analyst <span class="analyst">Brad Ball</span> ( BLL , news , people ) lowered his rating on the Reston, Va, company to "Neutral" from "Buy" and reduced his share price target to $1197, from $13</span> Shares of <span class="company">Sallie Mae</span> ( SLM , news , people ), formally known as SLM Corp, fell 79 cents, or 67 percent, to $1102 in afternoon trading The stock has ranged from $311 to $1289 over the past year Earlier this week, the company posted a fourth quarter profit, compared a loss in the same quarter a year ago, partly as a result of higher revenue from fees and interest But results missed Wall Street expectations Tweet this 

Ladenburg Thalman analyst Brad Ball lowered his rating on the Reston, Va, company to "Neutral" from "Buy" and reduced his share price target to $1197, from $13 Shares of Sallie Mae, formally known as SLM Corp, fell 79 cents, or 67 percent, to $1102 in afternoon trading The stock has ranged from $311 to $1289 over the past year Earlier this week, the company posted a fourth quarter profit, compared a loss in the same quarter a year ago, partly as a result of higher revenue from fees and interest But results missed Wall Street expectations 
Share:  <span class="sent">Ladenburg Thalman analyst <span class="analyst">Brad Ball</span> lowered his rating on the Reston, Va, company to "Neutral" from "Buy" and reduced his share price target to $1197, from $13</span> Shares of Sallie Mae, formally known as <span class="company">SLM</span> Corp, fell 79 cents, or 67 percent, to $1102 in afternoon trading The stock has ranged from $311 to $1289 over the past year Earlier this week, the company posted a fourth quarter profit, compared a loss in the same quarter a year ago, partly as a result of higher revenue from fees and interest But results missed Wall Street expectations...<span class="sent">Ladenburg Thalman analyst <span class="analyst">Brad Ball</span> lowered his rating on the Reston, Va, company to "Neutral" from "Buy" and reduced his share price target to $1197, from $13</span> Shares of Sallie Mae, formally known as <span class="company">SLM</span> Corp, fell 79 cents, or 67 percent, to $1102 in afternoon trading The stock has ranged from $311 to $1289 over the past year Earlier this week, the company posted a fourth quarter profit, compared a loss in the same quarter a year ago, partly as a result of higher revenue from fees and interest But results missed Wall Street expectations Tweet this